MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF
Technology
E-211-2016
Patent ID
E-211-2016-0-US-05
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
11066479
Publication Number
US-2020-0216558
Application Number
16/322,712
IC
NCI
Date Filed
Date Issued